TP53 and cancer: It has been suggested that site-specific DNA hypomethylation may be critical, such as the hypomethylation of the coding region (exons 5–8) of the p53 tumor suppressor gene, which is the most frequently mutated in human cancers (Kim et al., 1997; Choi and Mason, 2000).